Form 4: H.B. Fuller CFO Updates Equity Holdings
Insider Transaction Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, reported an acquisition of 152.89 phantom units and detailed his extensive equity holdings, including common stock, stock options, and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), reported changes in his beneficial ownership of company securities.
- On September 12, 2025, Corkrean acquired 152.89 phantom units.
- These phantom units convert into shares of common stock on a 1-for-1 basis and are part of a deferred compensation plan.
- The total beneficial ownership of phantom units following this transaction is 26,609.61, which includes units acquired via a dividend equivalent feature.
- Corkrean directly beneficially owns 52,196 shares of H.B. Fuller Common Stock.
- He also holds a significant number of Employee Stock Options (Right-to-Buy) with various exercise prices ranging from $43.48 to $77.72 and expiration dates extending to 2035.
- Additionally, Corkrean holds Restricted Stock Units (RSUs) totaling 8,491.26 units, which convert to common stock on a 1-for-1 basis and vest in annual installments.
Sentiment
Score: 7
Explanation: Routine disclosure of executive equity holdings, including a small acquisition of phantom units, generally viewed as neutral to slightly positive as it aligns executive interests with shareholders.
Positives
- The acquisition of phantom units by a key executive demonstrates continued equity participation and aligns management's interests with shareholder value.
- Significant existing equity holdings, including common stock, stock options, and restricted stock units, further reinforce the alignment of executive and shareholder interests.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The executive's significant equity ownership, including common stock, phantom units, stock options, and restricted stock units, enhances the alignment of management's financial interests with those of the shareholders, potentially fostering decisions that drive long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $43.48, 100% vested. |
| 01/26/2018 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $50.10, 100% vested. |
| 01/25/2019 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $53.57, 100% vested. |
| 01/24/2020 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $45.05, 100% vested. |
| 01/24/2021 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $48.35, 100% vested. |
| 01/27/2022 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $51.89, 100% vested. |
| 01/24/2023 | Grant date for Employee Stock Option (Right-to-Buy) with an exercise price of $72.94, 100% vested. |
| 01/24/2024 | Vesting start date for Restricted Stock Units (1,297.11 units) and vesting start date for Employee Stock Option (Right-to-Buy) with an exercise price of $68.17. |
| 01/26/2025 | Vesting start date for Restricted Stock Units (2,841.16 units) and vesting start date for Employee Stock Option (Right-to-Buy) with an exercise price of $77.72. |
| 09/12/2025 | Date of acquisition of 152.89 Phantom Units. |
| 01/24/2026 | Expiration date for Restricted Stock Units (1,297.11 units). |
| 01/27/2026 | Vesting start date for Restricted Stock Units (4,352.99 units) and vesting start date for Employee Stock Option (Right-to-Buy) with an exercise price of $64.28. |
| 05/17/2026 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $43.48. |
| 01/26/2027 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $50.10 and for Restricted Stock Units (2,841.16 units). |
| 01/27/2028 | Expiration date for Restricted Stock Units (4,352.99 units). |
| 01/25/2028 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $53.57. |
| 01/24/2029 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $45.05. |
| 01/24/2030 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $48.35. |
| 01/27/2031 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $51.89. |
| 01/24/2032 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $72.94. |
| 01/24/2033 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $68.17. |
| 01/26/2034 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $77.72. |
| 01/27/2035 | Expiration date for Employee Stock Option (Right-to-Buy) with an exercise price of $64.28. |
Recommendation
holdThis Form 4 filing is a routine disclosure of an executive's equity holdings and a minor acquisition of phantom units. It does not contain new material information that would warrant a change in investment recommendation. The executive's significant equity stake aligns their interests with shareholders, which is generally a positive, but it's not a catalyst for a 'buy' or 'sell' decision.
Keywords
H.B. Fuller, FUL, John J. Corkrean, Insider Transaction, Form 4, Executive Compensation, Phantom Units, Stock Options, Restricted Stock Units, Equity Holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.